Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC15955Rucaparib (AG-014699,PF-01367338) phosphateCAS: 459868-92-9纯度: >99.50%
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。
- GC15962Belinostat (PXD101)CAS: 414864-00-9
Belinostat (PXD101) 是 HeLa 细胞提取物中组蛋白脱乙酰酶 (HDAC) 活性的新型异羟肟酸型抑制剂,IC50 为 27 nM 。
- GC15964Clopidogrel hydrogen sulfateCAS: 120202-66-6纯度: >98.00% / >99.00%
Clopidogrel hydrogen sulfate是一种口服有效的嘌呤能P2Y12受体拮抗剂,对细胞色素P450(CYP)亚型CYP2B6和CYP2C19的IC 50 值分别为18.2nM和524nM。
- GC15970(6-)ε-Aminocaproic acidCAS: 60-32-2纯度: >99.00%
An inhibitor of plasmin activating enzymes
- GC15988KN-92 hydrochlorideCAS: 1431698-47-3纯度: >99.50%
KN-92 hydrochloride是KN-93的非活性类似物,可通过结构修饰转化为KN-93。
- GC16004NE 100 hydrochlorideCAS: 149409-57-4纯度: >98.00%
NE 100 hydrochloride是一种选择性sigma-1受体(IC 50 =4.16nM)拮抗剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC15947 | HC-030031 | 349085-38-7 | >98.00% | |
HC-030031是瞬时受体电位锚蛋白亚家族成员1(TRPA1)的选择性抑制剂。HC-030031可阻断细胞的钙流入,对肉桂醛和异硫氰酸烯丙酯(AITC)诱导的钙内流的IC 50 值分别为4.9±0.1和7.5±0.2μM。 | ||||
| GC15949 | Benfotiamine | 22457-89-2 | >99.00% | |
A lipid-soluble form of vitamin B 1 | ||||
| GC15951 | URB597 | 546141-08-6 | >99.00% | |
An inhibitor of FAAH | ||||
| GC15955 | Rucaparib (AG-014699,PF-01367338) phosphate | 459868-92-9 | >99.50% | |
Rucaparib (AG-014699,PF-01367338) phosphate是一种口服生物可利用的三环吲哚类聚(ADP-核糖)聚合酶(PARP)抑制剂。 | ||||
| GC15956 | WHI-P97 | 211555-05-4 | >99.00% | |
WHI-P97 是一种有效的选择性 JAK-3 抑制剂。 | ||||
| GC15962 | Belinostat (PXD101) | 414864-00-9 | - | |
Belinostat (PXD101) 是 HeLa 细胞提取物中组蛋白脱乙酰酶 (HDAC) 活性的新型异羟肟酸型抑制剂,IC50 为 27 nM 。 | ||||
| GC15964 | Clopidogrel hydrogen sulfate | 120202-66-6 | >98.00% / >99.00% | |
Clopidogrel hydrogen sulfate是一种口服有效的嘌呤能P2Y12受体拮抗剂,对细胞色素P450(CYP)亚型CYP2B6和CYP2C19的IC 50 值分别为18.2nM和524nM。 | ||||
| GC15965 | MC1568 | 852475-26-4 | - | |
A selective class IIa HDAC inhibitor | ||||
| GC15966 | Avermectin B1b | 65195-56-4 | >85.00% | |
An insecticide and anthelmintic | ||||
| GC15967 | GNE-617 hydrochloride | 2070014-99-0 | >99.00% | |
A potent Nampt inhibitor | ||||
| GC15970 | (6-)ε-Aminocaproic acid | 60-32-2 | >99.00% | |
An inhibitor of plasmin activating enzymes | ||||
| GC15973 | Tozadenant | 870070-55-6 | >99.50% | |
An adenosine A 2A receptor antagonist | ||||
| GC15980 | WP1066 | 857064-38-1 | >99.50% | |
WP1066是一种STAT3(信号转导和转录激活因子3)可逆的竞争性抑制剂,针对STAT3 Tyr705位点磷酸化的抑制IC 50 约为2.5μM,通常用于恶性肿瘤及炎症相关疾病的研究。 | ||||
| GC15984 | Deuterated Atazanivir-D3-1 | 1092540-56-1 | - | |
HIV-1 protease inhibitor | ||||
| GC15985 | Cariprazine | 839712-12-8 | >99.00% | |
An atypical antipsychotic | ||||
| GC15988 | KN-92 hydrochloride | 1431698-47-3 | >99.50% | |
KN-92 hydrochloride是KN-93的非活性类似物,可通过结构修饰转化为KN-93。 | ||||
| GC15989 | WZ811 | 55778-02-4 | >98.00% | |
CXCR4 antagonist | ||||
| GC15996 | Etravirine (TMC125) | 269055-15-4 | >99.50% | |
An NNRTI | ||||
| GC15997 | Casanthranol | 8024-48-4 | - | |
Casanthanol 是来自 cascara sagrada(鼠李干树皮的干燥树皮)的蒽酚糖苷的浓缩混合物。 | ||||
| GC15999 | IRAK-1-4 Inhibitor I | 509093-47-4 | >99.50% | |
A benzimidazole | ||||
| GC16004 | NE 100 hydrochloride | 149409-57-4 | >98.00% | |
NE 100 hydrochloride是一种选择性sigma-1受体(IC 50 =4.16nM)拮抗剂。 | ||||
| GC16008 | CUDC-101 | 1012054-59-9 | >99.00% | |
A multi-target inhibitor of HDACs, EGFR, and HER2 | ||||
| GC16009 | GSK3787 | 188591-46-0 | >99.00% | |
A selective, irreversible PPARβ/δ antagonist | ||||
| GC16012 | PF-04971729 | 1210344-57-2 | >98.00% | |
An SGLT2 inhibitor | ||||
